Chitosan-based hydrogels do not induce angiogenesis

Journal of Tissue Engineering and Regenerative Medicine

Volumn 4, Issue 4, 2010, Pages 309-315

  Ahmadi, Raheleh ^a   Burns, Alan J ^b   De Bruijn, Joost D ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Angiogenesis; Biphasic calcium phosphate microparticles; Chick chorioallantoic membrane assay; Chitosan glycerol phosphate hydroxyethyl cellulose; Injectable bone tissue engineering; Mesenchymal stem cells

Indexed keywords

BINDERS; BLOOD VESSELS; BONE; CALCIUM PHOSPHATE; CELL CULTURE; CELL ENGINEERING; CELLULOSE; GLYCEROL; TISSUE ENGINEERING;

ANGIOGENESIS; BIPHASIC CALCIUM PHOSPHATE MICROPARTICLE; BIPHASIC CALCIUM PHOSPHATES; BONE TISSUE ENGINEERING; CALCIUM PHOSPHATE MICROPARTICLES; CHICK CHORIOALLANTOIC MEMBRANE; CHICK CHORIOALLANTOIC MEMBRANE ASSAY; CHITOSAN-GLYCEROL PHOSPHATE-HYDROXYETHYL CELLULOSE; CHORIOALLANTOIC MEMBRANE ASSAYS; GLYCEROL PHOSPHATE; INJECTABLE BONE TISSUE ENGINEERING; INJECTABLES; MESENCHYMAL STEM CELL;

CHITOSAN;

CELLULOSE; CHITOSAN GLYCEROL PHOSPHATE HYDROXYETHYL CELLULOSE; UNCLASSIFIED DRUG; CALCIUM PHOSPHATE; CHITOSAN; HYDROGEL;

ADULT; ANGIOGENESIS; ARTICLE; BONE TISSUE; CELL ASSAY; CELL CULTURE; CHICK; CHORIOALLANTOIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; QUANTITATIVE STUDY; TISSUE ENGINEERING; ANIMAL; BIOASSAY; BLOOD VESSEL; CELL PROLIFERATION; CHICK EMBRYO; CYTOLOGY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HYDROGEL; MEMBRANE MICROPARTICLE; MESENCHYMAL STROMA CELL; METABOLISM; PHARMACOLOGY; VASCULARIZATION;

ADULT; ANIMALS; BIOLOGICAL ASSAY; BLOOD VESSELS; CALCIUM PHOSPHATES; CELL PROLIFERATION; CELL-DERIVED MICROPARTICLES; CHICK EMBRYO; CHITOSAN; CHORIOALLANTOIC MEMBRANE; FEMALE; HUMANS; HYDROGELS; MALE; MESENCHYMAL STROMAL CELLS; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 77953079863     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.247     Document Type: Article

References (52)

1. Akita S, Tamai N, Myoui A, et al. 2004; Capillary vessel network integration by inserting a vascular pedicle enhances bone formation in tissue-engineered bone using interconnected porous hydroxyapatite ceramics. Tissue Eng 10: 789-795. (Pubitemid 38880397)
2. Al-Khaldi A, Eliopoulos N, Martineau D, et al. 2003; Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo. Gene Ther 10: 621-629. (Pubitemid 36553607)
3. Auerbach R, Lewis R, Shinners B, et al. 2003; Angiogenesis assays: a critical overview. Clin Chem 49: 32-40.
4. Awwad HK, el Naggar M, Mocktar N, et al. 1986; Intercapillary distance measurement as an indicator of hypoxia in carcinoma of the cervix uteri. Int J Radiat Oncol Biol Phys 12: 1329-1333.
5. Benelli R, Morini M, Carrozzino F, et al. 2002; Neutrophils as a key cellular target for angiostatin: implications for regulation of angiogenesis and inflammation. FASEB J 16: 267-269.
6. Biagini G, Pugnaloni A, Frongia G, et al. 1989; N-Carboxymethyl chitosan induces neovascularization. In Chitin and Chitosan, Skjak-Braek G, Anthonsen T, Sandford P (eds). Elsevier Applied Science: London, New York; 671-677.
7. Carmeliet P, Jain RK. 2000; Angiogenesis in cancer and other diseases. Nature 407: 249-257.
8. Casabona F, Martin I, Muraglia A, et al. 1998; Prefabricated engineered bone flaps: an experimental model of tissue reconstruction in plastic surgery. Plast Reconstr Surg 101: 577-581. (Pubitemid 28113764)
9. Chen J, Li Y, Katakowski M, et al. 2003; Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res 73: 778-786. (Pubitemid 37071731)
10. Chenite A, Chaput C, Wang D, et al. 2000; Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials 21: 2155-2161. (Pubitemid 30612386)
11. Choong CS, Hutmacher DW, Triffitt JT. 2006; Co-culture of bone marrow fibroblasts and endothelial cells on modified polycaprolactone substrates for enhanced potentials in bone tissue engineering. Tissue Eng 12: 2521-2531.
12. de Castro-Bernas GC. 2003; Angiotherapeutics from natural products: from bench to clinics? Clin Hemorheol Microcirc 29: 199-203.
13. Deckers MM, Karperien M, van der Bent C, et al. 2000; Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 141: 1667-1674. (Pubitemid 32274395)
14. Druecke D, Langer S, Lamme E, et al. 2004; Neovascularization of poly(ether ester) block-copolymer scaffolds in vivo: long-term investigations using intravital fluorescent microscopy. J Biomed Mater Res A 68: 10-18. (Pubitemid 38030179)
15. Folkman J, Shing Y. 1992; Angiogenesis. J Biol Chem 267: 10931-10934.
16. Furumatsu T, Shen ZN, Kawai A, et al. 2003; Vascular endothelial growth factor principally acts as the main angiogenic factor in the early stage of human osteoblastogenesis. J Biochem133: 633-639. (Pubitemid 36759471)
17. Goldstein AS, Juarez TM, Helmke CD, et al. 2001; Effect of convection on osteoblastic cell growth and function in biodegradable polymer foam scaffolds. Biomaterials 22: 1279-1288.
18. Hirano S, Noishiki Y. 1985; The blood compatibility of chitosan and N-acylchitosans. J Biomed Mater Res 19: 413-417.
19. Hoemann CD, Sun J, Chrzanowski V, et al. 2002; Amultivalent assay to detect glycosaminoglycan, protein, collagen, RNA, and DNA content in milligram samples of cartilage or hydrogel-based repair cartilage. Anal Biochem 300: 1-10. (Pubitemid 34066797)
20. Hoemann CD, Sun J, Legare A, et al. 2005; Tissue engineering of cartilage using an injectable and adhesive chitosan-based cell-delivery vehicle. Osteoarthr Cartilage 13: 318-329. (Pubitemid 40361575)
21. Huang YC, Kaigler D, Rice KG, et al. 2005b; Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res 20: 848-857. (Pubitemid 40571642)
22. Kaigler D, Krebsbach PH, Polverini PJ, et al. 2003; Role of vascular endothelial growth factor in bone marrow stromal cell modulation of endothelial cells. Tissue Eng 9: 95-103. (Pubitemid 36228181)
23. Kamihata H, Matsubara H, Nishiue T, et al. 2001; Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104: 1046-1052. (Pubitemid 32803883)
24. Karageorgiou V, Kaplan D. 2005; Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 26: 5474-5491.
25. Kim WS, Kim HK. 2005; Tissue engineered vascularized bone formation using in vivo implanted osteoblast-polyglycolic acid scaffold. J Korean Med Sci 20: 479-482.
26. Kinnaird T, Stabile E, Burnett MS, et al. 2004; Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94: 678-685. (Pubitemid 38387752)
27. Kneser U, Kaufmann PM, Fiegel HC, et al. 1999; Long-term differentiated function of heterotopically transplanted hepatocytes on three-dimensional polymer matrices. J Biomed Mater Res 47: 494-503. (Pubitemid 29468553)
28. Kruyt MC, de Bruijn JD, Wilson CE, et al. 2003; Viable osteogenic cells are obligatory for tissue-engineered ectopic bone formation in goats. Tissue Eng 9: 327-336.
29. Laschke MW, Menger MD. 2007; In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis. Hum Reprod Update 13: 331-342. (Pubitemid 47062827)
30. Lawson MA, Barralet JE, Wang L, et al. 2004; Adhesion and growth of bone marrow stromal cells on modified alginate hydrogels. Tissue Eng 10: 1480-1491. (Pubitemid 39557851)
31. Leach JK, Kaigler D, Wang Z, et al. 2006; Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration. Biomaterials 27: 3249-3255. (Pubitemid 43344337)
32. Li Z, Ramay HR, Hauch KD, et al. 2005; Chitosan-alginate hybrid scaffolds for bone tissue engineering. Biomaterials 26: 3919-3928. (Pubitemid 40038783)
33. Marks MG, Shi J, Fry MO, et al. 2002; Effects of putative hydroxylated thalidomide metabolites on blood vessel density in the chorioallantoic membrane (CAM) assay and on tumor and endothelial cell proliferation. Biol Pharm Bull 25: 597-604. (Pubitemid 39663255)
34. Miller WJ, Kayton ML, Patton A, et al. 2004; A novel technique for quantifying changes in vascular density, endothelial cell proliferation and protein expression in response to modulators of angiogenesis using the chick chorioallantoic membrane (CAM) assay. J TranslMed 2: 4.
35. Mochizuki M, Philp D, Hozumi K, et al. 2007; Angiogenic activity of syndecan-binding laminin peptide AG73 (RKRLQVQLSIRT). Arch Biochem Biophys 459: 249-255.
36. Muzzarelli RA. 1997; Human enzymatic activities related to the therapeutic administration of chitin derivatives. Cell Mol Life Sci 53: 131-140.
37. Nagaya N, Fujii T, Iwase T, et al. 2004; Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acutemyocardial infarction through angiogenesis andmyogenesis. Am J Physiol Heart Circ Physiol 287: H2670-2676.
38. Oates M, Chen R, Duncan M, et al. 2007; The angiogenic potential of three-dimensional open porous synthetic matrix materials. Biomaterials 28: 3679-3686.
39. Perets A, Baruch Y, Weisbuch F, et al. 2003; Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J Biomed Mater Res A 65: 489-497.
40. Pinney E, Liu K, Sheeman B, et al. 2000; Human three-dimensional fibroblast cultures express angiogenic activity. J Cell Physiol 183: 74-82.
41. Potapova IA, Gaudette GR, Brink PR, et al. 2007; Mesenchymal stem cells support migration, extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro. Stem Cells 25: 1761-1768.
42. Ribatti D, Urbinati C, Nico B, et al. 1995; Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane. Dev Biol 170: 39-49.
43. Ribatti D, Vacca A, Roncali L, et al. 2000; The chick embryo chorioallantoic membrane as a model for in vivo research on anti-angiogenesis. Curr Pharm Biotechnol 1: 73-82.
44. Richardson TP, Peters MC, Ennett AB, et al. 2001; Polymeric system for dual growth factor delivery. Nat Biotechnol 19: 1029-1034. (Pubitemid 33041886)
45. Rifkin DB, Moscatelli D. 1989; Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol 109: 1-6. (Pubitemid 19180114)
46. Roughley P, Hoemann C, DesRosiers E, et al. 2006; The potential of chitosan-based gels containing intervertebral disc cells for nucleus pulposus supplementation. Biomaterials 27: 388-396. (Pubitemid 41457242)
47. Rouwkema J, de Boer J, Van Blitterswijk CA. 2006; Endothelial cells assemble into a three-dimensional prevascular network in a bone tissue engineering construct. Tissue Eng 12: 2685-2693. (Pubitemid 46141291)
48. Staton CA, Stribbling SM, Tazzyman S, et al. 2004; Current methods for assaying angiogenesis in vitro and in vivo. Int J Exp Pathol 85: 233-248. (Pubitemid 39319155)
49. Steinbrech DS, Mehrara BJ, Saadeh PB, et al. 1999; Hypoxia regulates VEGF expression and cellular proliferation by osteoblasts in vitro. Plast Reconstr Surg 104: 738-747.
50. Tang YL, Zhao Q, Qin X, et al. 2005; Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann Thorac Surg 80: 229-236; discussion. 236-1227 (Pubitemid 40840214)
51. Thomas KA. 1996; Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 271: 603-606. (Pubitemid 26034900)
52. Yang S, Leong KF, Du Z, et al. 2001; The design of scaffolds for use in tissue engineering. Part I. Traditional factors. Tissue Eng 7: 679-689. (Pubitemid 34042301)